Colonoscopy in surveillance of inflammatory bowel disease.
Patients with chronic colitis from inflammatory bowel disease (IBD), whether ulcerative colitis or Crohn's disease, have an increased risk of colorectal cancer (CRC), which accounts for approximately 10-15% of all deaths among IBD patients. The risk of CRC increases with disease duration and is freq...
| Publicado en: | Gastrointestinal Nursing Vol. 9; no. 8; pp. 20 - 27 |
|---|---|
| Autores principales: | , |
| Formato: | algorithm critical path pictorial Journal Article |
| Publicado: |
Mark Allen Holdings Limited
Oct2011
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=67123694&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 67123694 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 14795248 1FTK jtl: Gastrointestinal Nursing issn: 14795248 maglogo: N pubinfo: dt: Oct2011 vid: 9 iid: 8 pid: 11383 pub: Mark Allen Holdings Limited artinfo: ui: 67123694 104639777 104639777 10.12968/gasn.2011.9.8.20 67123694 ppf: 20 ppct: 7 formats: fmt: @attributes: type: P tig: atl: Colonoscopy in surveillance of inflammatory bowel disease. aug: au: Ahmad, Saqib Ragunath, Krish affil: Specialist trainee in gastroenterology, Nottingham Digestive Diseases Centre and NIHR Biomedical Research Unit, Queens Medical Centre, Nottingham University Hospitals NHS Trust sug: subj: Colonoscopy Methods Disease Surveillance Methods Inflammatory Bowel Diseases Colorectal Neoplasms Risk Factors Cancer Screening Methods Colorectal Neoplasms Diagnosis Biopsy Early Diagnosis Dyes Risk Assessment Colitis, Ulcerative Crohn Disease Inflammatory Bowel Diseases Therapy ab: Patients with chronic colitis from inflammatory bowel disease (IBD), whether ulcerative colitis or Crohn's disease, have an increased risk of colorectal cancer (CRC), which accounts for approximately 10-15% of all deaths among IBD patients. The risk of CRC increases with disease duration and is frequently preceded by the pre-cancerous histological stage called dysplasia. In an attempt to detect dysplasia and asymptomatic cancers in patients with IBD, most national gastroenterology societies recommend initiating colonoscopy surveillance after 8 to 10 years of diagnosis. The goal of surveillance is to reduce the risk of cancer and mortality due to CRC. Current studies of surveillance using chromoendoscopy (dye spray) have demonstrated improved detection of dysplasia compared to conventional colonoscopy surveillance and have changed the approach from random to targeted biopsies. In this article, Saqib Ahmad and Krish Ragunath aim to discuss chromoendoscopy in detail with brief discussion about management of dysplasia. pubtype: Academic Journal doctype: algorithm critical path pictorial Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|